Abstract. The present study investigated the diurnal variation in GH receptor (GHR) mRNA in liver and skeletal muscle of 3-month-old GH-deficient and -sufficient mice using quantitative real-time RT-PCR. lit/lit (GH deficient) or lit/+ (GH sufficient) mice were fed ad libitum and lights were on between
THE biological actions of growth hormone (GH) are initiated by the binding of GH to GH receptor (GHR) [1] . The number and function of GHR affect the ability of a tissue to respond to GH [2] . GHR messenger ribonucleic acid (mRNA) expression has been reported to be regulated by various factors, including insulin [3] , glucocorticoids [4] , GH [5] and nutritional status [6] , and the regulation is tissue specific. It is known that there is a circadian pattern of circulating cortisol in rodents and humans [7, 8] and GH secretion is pulsatile in these species [9, 10] . These findings led us to hypothesize that there might be diurnal variation in the expression level of GHR mRNA which might regulate GHR signaling in vivo. Diurnal changes in circulating IGF-I have been reported in healthy adults [11] . Furthermore, we recently reported that hepatic GHR and IGF-I mRNA levels were correlated in chronic GH excess and deficiency in mice [12] . Therefore, it is possible that there is diurnal variation in hepatic IGF-I as well as in GHR mRNA expression. In skeletal muscle, GH also elicits its effects on protein synthesis by binding to GHR and increasing muscle gene transcription, including IGF-I expression [13] . On the other hand, there is the evidence of GH-independent expression of IGF-I in skeletal muscle [14] . It might be speculated that the relation between GHR and IGF-I mRNA in skeletal muscle is different from that in liver.
The lit/lit mouse is a model of isolated GH deficiency with an inactivating mutation in the GH releasing hormone receptor [15] . Furthermore, it has been reported that circulating insulin levels of mice with decreased GH action were low [16] . Therefore, to eluci-date the effects of GH and insulin levels on diurnal mRNA expressions of GHR and IGF-I, we used these GH deficient mice and their heterozygous lit/+ littermates as controls, which are GH sufficient. In the present study, we investigated: 1) the possibility of diurnal variation in GHR and IGF-I mRNA levels in liver and skeletal muscle; 2) the influence of GH deficiency and insulin levels on the diurnal variation in these genes in liver and skeletal muscle.
Materials and Methods
Animals and tissue collection 3-month-old male lit/lit and lit/+ mice (Jackson Labs, Bar Harbor, ME) were used in this study. The mice were maintained under environmental conditions of temperature (21 ± 2°C) and humidity (30-70%) with lights on between 0600 and 2000. The mice had free access to 5K52 diet (LabDiet, St. Louis, MO) and water.
Liver and gastrocnemius muscle were collected between 0800-1000, 1200-1400 and 2000-2200 (n = 5 to 6 for each group), and immediately frozen in liquid nitrogen and stored at -80°C. All animal procedures were approved by the Institutional Animal Care and Use Committee of the University of Virginia.
Quantification of mRNA
RNA extraction and two-step reverse transcriptionpolymerase chain reaction (RT-PCR) were performed as described [12] . Briefly, the RNA was extracted from the liver and gastrocnemius muscle using TRI REAGENT (Molecular Research Center, Inc. Cincinnati, OH) followed by further purification using the RNeasy Mini Kit and DNase I treatment (Qiagen, Valencia, CA). RNA concentrations were determined using the Ribogreen Quantitation Kit (Molecular Probes, Eugene, OR) in a Genios multi-detection plate reader (Phoenix Research Product, Hayward, CA).
Primers for murine GHR, and IGF-I were designed to produce amplification products which spanned two exons (exon 3 and 4 for IGF-I, and exon 9 and 10 for GHR) of the protein coding sequence to avoid amplification of genomic DNA. All samples were normalized to 18S ribosomal RNA (rRNA) amplified. Primer sequences and the expected size of RT-PCR products are as follows: GHR (forward: 5'-GATTTTACCCCCAG TCCCAGTTC-3', reverse: 5'-GACCCTTCAGTCTT CTCATCCACA-3', product 198 bp), IGF-I (forward: 5'-GTGTGGACC GAGGGGCTTTTACTT C-3', reverse: 5'-GCTTCAGTGGGGCACAGTACATCT C-3', product 146 bp), and 18S rRNA (forward: 5'-TCAA GAACGAAAGTCGGAGG-3', reverse: 5'-GGACAT CTAAGGGCATCACA-3', product 489 bp). The primers of 18S rRNA were designed as previously reported [17] . The primer pairs to amplify the GHR coded exclusively for GHR and not for GHBP since they were directed to the intracellular domain of GHR. Total RNA from skeletal muscle and liver were reverse transcribed using the iScript cDNA Synthesis Kit (Bio Rad Laboratories, Hercules, CA).
Expression levels of GHR and IGF-I were quantified using the iCycler iQ Real-Time PCR Detection System (Bio-Rad, Hercules, CA). SYBR Green I was used for detection of PCR products. The real-time PCR protocol was 5 min at 95°C, followed by 35 cycles of 15 sec at 94°C, 40 sec at 62°C, and 45 sec at 72°C. To assess PCR specificity, melting curves from 55-95°C in 0.5°C steps of 10 sec each were generated. PCR products of each assay were also subjected to agarose gel electrophoresis to confirm amplification specificity.
A standard curve was generated by amplifying serial dilutions of a known quantity of plasmid (pGEM-T; Promega, Madison, WI) including each PCR product. The standards and cDNA samples were amplified in the same reaction plate. The amount of product in a particular sample was determined by interpolation from a standard curve of cycle threshold (C T ) values generated from the plasmid dilution series. PCR efficiencies of all reactions were between 95% and 100%. All measurements were performed in triplicate.
Serum measurements
Blood was obtained by heart puncture at the time of sacrifice, and serum was separated and stored at -80°C until assayed. Circulating insulin concentrations were measured in serum of lit/+ and lit/lit mice using radioimmunoassay as described previously [18] . The lower limit of detection value was 1.24 ng/ml.
Statistical analysis
Expression levels of GHR and IGF-I mRNA are represented as mean ± SEM. Differences were deter-mined by one-way ANOVA using GraphPad Prism Software version 4.00 for Windows (GraphPad Software Inc, San Diego, CA). P<0.05 was considered significant. Since insulin levels were undetectable in most lit/lit mice, the lower limit of detection value was used for statistical analysis.
Results

Diurnal variation in GHR mRNA levels
There was diurnal variation in GHR mRNA in liver and skeletal muscle. Hepatic GHR mRNA levels of lit/+ mice at 2000-2200 and 1200-1400 were 1.9 and 2.0 fold of those at 0800-1000 (P<0.05) (Fig. 1A) . Hepatic GHR mRNA of lit/lit mice at 2000-2200 tended to be higher than those at 0800-1000 and 1200-1400, but it was not significant (Fig. 1B) . In gastrocnemius muscle, GHR mRNA levels of lit/+ mice at 1200-1400 were 1.9 and 3.3 fold of those at 2000-2200 and 0800-1000, respectively (P<0.05) (Fig. 2A) . Similarly, those of lit/lit mice at 1200-1400 were 3.0 and 2.2 fold of those at 2000-2200 or 0800-1000 (P<0.05) (Fig. 2B) . In muscle of both lit/+ and lit/lit mice, there was no significant difference in GHR mRNA between 2000-2200 and 0800-1000.
IGF-I mRNA expression
Hepatic IGF-I mRNA levels varied in parallel with GHR mRNA both in lit/+ and lit/lit mice. Hepatic IGF-I mRNA levels of lit/+ mice at 2000-2200 and 1200-1400 were 2.0 and 3.1 fold of those at 0800-1000 (P<0.05) (Fig. 1C) . In contrast, those of lit/lit mice were not significantly different (Fig. 1D ). There was no significant variation in IGF-I mRNA levels in skeletal muscle of lit/+ and lit/lit mice (Fig. 2C, D) .
Serum Insulin level
Serum insulin levels of lit/+ mice at 1200-1400 were significantly lower compared to those at 0800-1000 or 2000-2200 (Table 1) . However, insulin levels were not detectable in most lit/lit mice. Serum insulin levels of lit/lit mice were significantly lower than those of lit/+ mice at all three time points.
Discussion
The present study demonstrated a diurnal variation in GHR mRNA in liver and skeletal muscle. Circadian variation in hepatic GHR mRNA was found in lit/+ mice but not in lit/lit mice. Diurnal variation in GHR mRNA was found in skeletal muscle of both lit/+ and lit/lit mice. In lit/+ mice, the patterns of variation in GHR mRNA were different between liver and skeletal muscle. Whereas there was a diurnal change in hepatic IGF-I mRNA levels of lit/+ mice, it was not evident in those of lit/lit mice. Furthermore, there was no significant variation in IGF-I mRNA levels in muscle of either lit/+ or lit/lit mice.
The mechanisms responsible for the diurnal change in GHR mRNA are not clear. However, some possible factors are considered to be the candidates; these include insulin [3, 19] , glucocorticoids [4, 20] and GH [5, [21] [22] [23] [24] .
Effects of insulin on GHR expression have been reported. Studies in vitro showed insulin increased GHR mRNA levels in human hepatoma cells [3] , and down-regulated those in osteoblast [25] . In vivo, GHR mRNA levels were decreased in liver of streptozotocininduced diabetic rats [19] . GH binding to the liver was reduced in diabetic rats and was increased with insulin treatment [26] . Taken together, these reports indicate that insulin regulates hepatic GHR not only at the mRNA level but also at the protein level on the cell surface. The present study found variations of serum insulin levels of lit/+ mice; the levels were higher at 2000-2200 and 0800-1000 and lower at 1200-1400 (middle of light phase when the animals were asleep/resting). Moreover, serum insulin levels of lit/lit mice were significantly lower than those of lit/+ mice, suggesting that decreased insulin levels may be, at least in part, responsible for blunted diurnal variation in hepatic GHR mRNA of lit/lit mice. However, our results showed that serum insulin levels were not in parallel with hepatic GHR mRNA expressions in lit/+ mice, suggesting that other factors as well as insulin affected the hepatic GHR expression. In skeletal muscle, insulin is one of the regulators of GHR expression. Katsumata et al. reported that undernutrition with low serum insulin levels caused up-regulation of GHR mRNA in porcine muscle [27] .This contrast with the down-regulation of hepatic GHR mRNA that was observed in fasted state in rats [6] and humans [28] . Our results in skeletal muscle of lit/+ mice are in agreement with the report by Katsumata et al. demonstrating that lower serum insulin levels were associated with high mRNA expression of GHR. However, this explanation is not true of lit/lit mice with unchanged extremely low serum insulin levels. Therefore, we speculate that other factors as well as insulin also affected the GHR mRNA expression in skeletal muscle.
Another possible factor is circulating glucocorticoids. Glucocorticoids have been reported to affect GHR expression. Dexamethasone inhibited the induction of GHR mRNA by GH in rat primary cultured hepatocytes [20] . In vivo, dexamethasone down-regulated hepatic GHR mRNA and protein in the rats [4] . It is well known that there is a circadian pattern of circulating cortisol in the human; higher in the morning than in the evening [7, 29] . In rats, Windle et al. reported that circulating corticosterone displayed a circadian variation; the mean corticosterone concentrations were significantly higher in the dark phase than in the light phase [8] . In the same study, the mean hourly value of corticosterone was highest just before the onset of the dark phase and lowest in the early light phase. Our results showed that hepatic GHR mRNA levels of lit/+ mice were lower at 0800-1000, just after the dark phase. This suggests that increased circulating corticosterone in the dark phase might contribute to the down-regulation of hepatic GHR mRNA in the early light phase (0800-1000). Alternatively, hepatic GHR mRNA levels of lit/+ mice were higher at 1200-1400 and at the onset of the dark phase (2000-2200), suggesting that decreased corticosterone levels during the light phase might play a role in these changes. However, because there are few reports regarding the effect of GH deficiency on circadian rhythm of corticosterone, it is difficult to interpret the results of hepatic GHR mRNA of lit/lit mice with this factor. GH secretion is pulsatile in rodents and humans [9, 10] . The circulating concentrations of GH in lit/lit mouse are reduced to less than 5% of normal and it lacks pulsatility [15, [30] [31] [32] . In our study, although diurnal variation in hepatic GHR mRNA was found in lit/+ mice, there was no significant variation in that of lit/lit mice. Thus, it is likely that the GH pulsatility and/or GH sufficient status is essential for the diurnal variation in hepatic GHR mRNA. In contrast, an interesting finding of this study is the diurnal change in GHR mRNA in skeletal muscle both of lit/+ and lit/lit mice. This suggests that in muscle, the effect of GH secretion pattern and/or GH deficiency on the diurnal variation in GHR mRNA is less than that in liver. Although the mechanisms that are responsible for the diurnal variation in GHR mRNA are still not clear, we believe that this is the first report describing the tissue-specific diurnal variation in GHR mRNA expression.
There was a diurnal change in hepatic IGF-I mRNA levels of lit/+ mice. Hepatic IGF-I mRNA levels of lit/+ mice were lower at 0800-1000, in parallel with GHR mRNA. There was no significant change in hepatic IGF-I mRNA of lit/lit mice and this result also correlated with GHR mRNA. Interestingly, these variations were not observed for IGF-I mRNA in skeletal muscle of either lit/+ or lit/lit mice. This suggests that the mechanisms of regulation of IGF-I mRNA in skeletal muscle are different from those in liver. Recently, we found a significant correlation between GHR mRNA and IGF-I mRNA in liver of normal, chronic GH excess and deficient mice [12] . The same study suggested that regulation of GHR and IGF-I mRNA levels was tissue-specific, supporting our present results that the relation of GHR mRNA to IGF-I mRNA was different between liver and skeletal muscle. GH increases IGF-I mRNA expression in various tissues, including liver and skeletal muscle [33, 34] . However, GH-independent IGF-I expression in skeletal muscle has been also reported [14, 35] . Pell et al. showed that IGF-I mRNA in muscle was not increased by GH treatment in sheep [35] . Another study found that there was a lack of correlation between serum GH and IGF-I mRNA levels in skeletal muscle of cattle, whereas hepatic IGF-I mRNA correlated with GH [14] . Therefore, it seems that IGF-I gene expression in skeletal muscle is regulated by GH-dependent and GH-independent mechanisms.
In conclusion, a diurnal variation in GHR mRNA levels in liver and skeletal muscle has been demonstrated in GH sufficient mouse. The diurnal regulation of GHR mRNA and its relation to IGF-I mRNA is tissuespecific.
